the effect of fennel on vaginal dryness

The comparison of the efficacy Foeniculum vulgare and placebo on atrophy vaginal and sexual function in postmenopausal women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016091628789N2

Enrollment

Registered

2016-11-11

Start date

2014-05-12

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vagnal atrophy. Postmenopausal atrophic vaginitis

Interventions

Intervention 1: Foeniculum vulgare 30 mg soft capsule, three times a day,12 week. Intervention 2: placebo capsule 30 mg soft capsule, three times a day,12 week.

Treatment - Drugs

Foeniculum vulgare 30 mg soft capsule, three times a day,12 week

placebo capsule 30 mg soft capsule, three times a day,12 week

Eligibility

Sex/Gender

Female

Age

44 Years to 64 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were: postmenopausal status, which was defined as aged between 45-65 with no vaginal bleeding for 1 year; no regular ingestion of phytoestrogen or soy-based products; having a normal mammogram in the last year; vaginal infection; smoking; Currently (or in the past 6 months) using estrogen ; no regular physical exercise; allergy to Foeniculum vulgare

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Atrophy Vaginal. Timepoint: before and three months after intervention. Method of measurement: Maturation index.;Marital satisfaction. Timepoint: before and three months after intervention. Method of measurement: Marital Satisfaction Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Tafaghodi

Mashhad University of Medical Sciences

tafaghodim@mums.ac.ir+98 51 3843 7840

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026